Drug Markets/Doravirine

Doravirine

1 NDC across 1 manufacturer|0 Generic,1 Brand

▸ More about this market

The brand product was first FDA-approved on Aug 30, 2018. In 2024, Medicare Part D spent $79 million on Doravirine across 42,000 claims for 4,774 beneficiaries.

Doravirine is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $60.79 to $60.79 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$60.79 – $60.79

per EA

7d Activity

1↑0 flat

avg +0.1% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing DORAVIRINE

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
PIFELTRO 100 MG TABLET
$60.7869
per EA
+0.14%

Frequently Asked Questions

How much does Medicare spend on Doravirine?

In 2024, Medicare Part D spent $79 million on Doravirine across 42,000 claims for 4,774 beneficiaries.

How many Doravirine products are on the market?

The Doravirine drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Doravirine?

NADAC reference prices for Doravirine range from $60.7869 to $60.7869 per EA.

Which manufacturers make Doravirine?

1 manufacturer lists Doravirine in NADAC. Ranked by number of NDCs, the largest are Merck Sharp & Dohme LLC (1).

How has the price of Doravirine changed recently?

Over the past 7 days, 1 Doravirine NDC rose and 0 fell, with a market-wide average change of +0.1%.